2seventy bio to Participate in the 2025 TD Cowen Healthcare Conference
February 25 2025 - 6:00AM
Business Wire
2seventy bio, Inc. (Nasdaq: TSVT), announced today that members
of the management team will participate in a fireside chat at the
upcoming TD Cowen 45th Annual Healthcare Conference on March 5,
2025 at 11:10 a.m. ET in Boston, Mass.
A live webcast of the fireside chat will be available via the
Investors and Media section of 2seventy bio’s website at
https://ir.2seventybio.com/. Replays will be archived on 2seventy
bio’s site for 30 days following the event.
About 2seventy bio
Our name, 2seventy bio, reflects why we do what we do - TIME.
Cancer rips time away, and our goal is to work at the maximum speed
of translating human thought into action – 270 miles per hour – to
give the people we serve more time. With a deep understanding of
the human body’s immune response to tumor cells and how to
translate cell therapies into practice, we’re applying this
knowledge to deliver the first FDA-approved CAR T cell therapy for
multiple myeloma to as many patients as possible. Importantly, we
remain focused on accomplishing our mission by staying genuine and
authentic to our “why” and keeping our people and culture top of
mind every day.
For more information, visit www.2seventybio.com.
Follow 2seventy bio on social media: X (Twitter) and
LinkedIn.
2seventy bio is a trademark of 2seventy bio, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250225987379/en/
Investors and Media: Vicki Eatwell, CFO
vicki.eatwell@2seventybio.com
Morgan (Adams) Shields Morgan.adams@2seventybio.com
2seventy bio (NASDAQ:TSVT)
Historical Stock Chart
From Jan 2025 to Feb 2025
2seventy bio (NASDAQ:TSVT)
Historical Stock Chart
From Feb 2024 to Feb 2025